Report cover image

Venlafaxine Global Market Report 2025

Published Jun 17, 2025
Length 175 Pages
SKU # BRC20111217

Description

Venlafaxine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on venlafaxine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for venlafaxine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The venlafaxine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Formulation: Extended-Release Capsules; Immediate-Release Tablets; Oral Solution

2) By Drug Class: Antidepressant; Selective Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs)

3) By Demographic: Adult; Pediatric; Geriatric

4) By Application: Panic Disorder; Depression; Anxiety; Social Anxiety Disorder; Other Application

5) By End-User: Clinic; Hospital; Other End-Users

Subsegments:

1) By Extended-Release Capsules: 37.5 Mg Capsules; 75 Mg Capsules; 150 Mg Capsules; 225 Mg Capsules

2) By Immediate-Release Tablets: 25 Mg Tablets; 37.5 Mg Tablets; 50 Mg Tablets; 75 Mg Tablets; 100 Mg Tablets

3) By Oral Solution: 25 Mg/Ml Oral Solution; 37.5 Mg/Ml Oral Solution; 50 Mg/Ml Oral Solution

Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi SA; Thermo Fisher Scientific Inc.; AstraZeneca plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Venlafaxine Market Characteristics
3. Venlafaxine Market Trends And Strategies
4. Venlafaxine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Venlafaxine Growth Analysis And Strategic Analysis Framework
5.1. Global Venlafaxine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Venlafaxine Market Growth Rate Analysis
5.4. Global Venlafaxine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Venlafaxine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Venlafaxine Total Addressable Market (TAM)
6. Venlafaxine Market Segmentation
6.1. Global Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Extended-Release Capsules
Immediate-Release Tablets
Oral Solution
6.2. Global Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antidepressant
Selective Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs)
6.3. Global Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adult
Pediatric
Geriatric
6.4. Global Venlafaxine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Panic Disorder
Depression
Anxiety
Social Anxiety Disorder
Other Application
6.5. Global Venlafaxine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinic
Hospital
Other End-Users
6.6. Global Venlafaxine Market, Sub-Segmentation Of Extended-Release Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
37.5 mg Capsules
75 mg Capsules
150 mg Capsules
225 mg Capsules
6.7. Global Venlafaxine Market, Sub-Segmentation Of Immediate-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25 mg Tablets
37.5 mg Tablets
50 mg Tablets
75 mg Tablets
100 mg Tablets
6.8. Global Venlafaxine Market, Sub-Segmentation Of Oral Solution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25 mg/mL Oral Solution
37.5 mg/mL Oral Solution
50 mg/mL Oral Solution
7. Venlafaxine Market Regional And Country Analysis
7.1. Global Venlafaxine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Venlafaxine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Venlafaxine Market
8.1. Asia-Pacific Venlafaxine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Venlafaxine Market
9.1. China Venlafaxine Market Overview
9.2. China Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Venlafaxine Market
10.1. India Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Venlafaxine Market
11.1. Japan Venlafaxine Market Overview
11.2. Japan Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Venlafaxine Market
12.1. Australia Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Venlafaxine Market
13.1. Indonesia Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Venlafaxine Market
14.1. South Korea Venlafaxine Market Overview
14.2. South Korea Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Venlafaxine Market
15.1. Western Europe Venlafaxine Market Overview
15.2. Western Europe Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Venlafaxine Market
16.1. UK Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Venlafaxine Market
17.1. Germany Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Venlafaxine Market
18.1. France Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Venlafaxine Market
19.1. Italy Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Venlafaxine Market
20.1. Spain Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Venlafaxine Market
21.1. Eastern Europe Venlafaxine Market Overview
21.2. Eastern Europe Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Venlafaxine Market
22.1. Russia Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Venlafaxine Market
23.1. North America Venlafaxine Market Overview
23.2. North America Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Venlafaxine Market
24.1. USA Venlafaxine Market Overview
24.2. USA Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Venlafaxine Market
25.1. Canada Venlafaxine Market Overview
25.2. Canada Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Venlafaxine Market
26.1. South America Venlafaxine Market Overview
26.2. South America Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Venlafaxine Market
27.1. Brazil Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Venlafaxine Market
28.1. Middle East Venlafaxine Market Overview
28.2. Middle East Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Venlafaxine Market
29.1. Africa Venlafaxine Market Overview
29.2. Africa Venlafaxine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Venlafaxine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Venlafaxine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Venlafaxine Market Competitive Landscape And Company Profiles
30.1. Venlafaxine Market Competitive Landscape
30.2. Venlafaxine Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
31. Venlafaxine Market Other Major And Innovative Companies
31.1. Novartis AG
31.2. Takeda Pharmaceutical Company Limited.
31.3. Viatris Inc.
31.4. Teva Pharmaceutical Industries
31.5. Sun Pharmaceutical Industries Ltd.
31.6. Aurobindo Pharma
31.7. Dr Reddy's Laboratories.
31.8. Zydus Cadila
31.9. Lupin Pharmaceuticals
31.10. Torrent Pharmaceuticals
31.11. Taylor & Francis
31.12. Stada Arzneimittel
31.13. Taj Pharma
31.14. Mesha Pharma
31.15. Suzhou Pharmaceutical
32. Global Venlafaxine Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Venlafaxine Market
34. Recent Developments In The Venlafaxine Market
35. Venlafaxine Market High Potential Countries, Segments and Strategies
35.1 Venlafaxine Market In 2029 - Countries Offering Most New Opportunities
35.2 Venlafaxine Market In 2029 - Segments Offering Most New Opportunities
35.3 Venlafaxine Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.